Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
IO-108 by Immune Onc Therapeutics for Colorectal Cancer: Likelihood of Approval
IO-108 is under clinical development by Immune Onc Therapeutics and currently in Phase I for Colorectal Cancer. According to GlobalData,...
IO-108 by Immune Onc Therapeutics for Solid Tumor: Likelihood of Approval
IO-108 is under clinical development by Immune Onc Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData,...
IO-108 by Immune Onc Therapeutics for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
IO-108 is under clinical development by Immune Onc Therapeutics and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According...